How Significant Is The Future Market Potential Of The Complete Blood Count Device Market Based On Its Projected Size And Growth Rate?
The complete blood count device market size has grown strongly in recent years. It will grow from $4.33 billion in 2025 to $4.58 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to expansion of clinical diagnostic testing volumes, increased hospital laboratory automation, growing burden of chronic diseases, availability of standardized blood testing protocols, rising demand for routine health screenings.
The complete blood count device market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing adoption of decentralized diagnostics, rising investments in smart laboratory infrastructure, growing demand for rapid diagnostic results, expansion of preventive healthcare testing, continuous advancements in hematology technology. Major trends in the forecast period include increasing adoption of automated hematology analyzers, rising demand for point-of-care cbc devices, growing integration of ai-based diagnostics, expansion of high-throughput laboratory systems, enhanced focus on diagnostic accuracy and speed.
Claim Your Free Report Sample Today:
What Essential Growth Drivers Are Pushing The Complete Blood Count Device Market Forward?
The growing prevalence of blood disorders is expected to propel the growth of the complete blood count device market going forward. Blood disorders are conditions that disrupt the production, function, or structure of blood cells, resulting in impaired blood function. The rise in blood disorders is linked to the growing occurrence of lifestyle diseases, where poor diet, inactivity, and stress lead to conditions such as anemia and clotting issues. A complete blood count (CBC) device aids in diagnosing blood disorders by analyzing key blood components and detecting abnormalities, allowing healthcare professionals to identify clotting disorders and ensuring prompt and precise treatment. For instance, in May 2024, according to the Canadian Cancer Society, a Canada-based organization, 4,100 individuals were diagnosed with multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Therefore, the growing prevalence of blood disorders is driving the growth of the complete blood count device market.
Which Segment Groups Play A Crucial Role In Outlining The Complete Blood Count Device Market’s Structure?
The complete blood count device market covered in this report is segmented –
1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers
2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types
3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy
4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers
5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers
2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents
3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits
4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers
What Current Industry Trends Are Affecting The Performance Of The Complete Blood Count Device Market?
Major companies operating in the complete blood count device market are focusing on developing advanced products, such as compact hematology analyzers, to provide more accurate, faster, and cost-effective solutions for point-of-care testing. Compact hematology analyzers are portable, user-friendly devices that provide quick, accurate, complete blood count (CBC) results with minimal sample volume, making them ideal for point-of-care use, enhancing diagnostic accuracy, efficiency, and ease of use while being cost-effective and easy to maintain. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, launched the Yumizen H550E and H500E hematology analyzers. These compact devices integrate erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, utilizing HORIBA's patented CoRA (correlated rouleaux analysis) technology to provide comprehensive results from whole blood samples in just 60 seconds.
Which Companies Represent The Key Strategic Forces Within The Complete Blood Count Device Market?
Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.
Get Your In-Depth Complete Blood Count Device Market Report Now:
Which Regional Clusters Are Forecasted To Outperform Others In The Complete Blood Count Device Market?
North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment